Skip to main content

Table 4 CGI-SI scale at baseline and 24w

From: Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism

Scale Baseline 24w
Combination CBMNC Control *Combinationab *CBMNCa Control
0 - n(%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 1(7.69%)
1 - n(%) 0(0.00%) 0(0.00%) 0(0.00%) 1(11.11%) 0(0.00%) 0(0.00%)
2 - n(%) 0(0.00%) 0(0.00%) 0(0.00%) 0(0.00%) 1(7.14%) 0(0.00%)
3 - n(%) 2(22.22%) 1(7.14%) 1(7.14%) 5(55.56%) 4(28.57%) 0(0.00%)
4 - n(%) 2(22.22%) 5(35.71%) 7(50.00%) 3(33.33%) 4(28.57%) 12(92.31%)
5 - n(%) 2(22.22%) 1(7.14%) 3(21.43%) 0(0.00%) 2(14.29%) 0(0.00%)
6 - n(%) 3(33.33%) 6(42.86%) 3(21.43%) 0(0.00%) 2(14.29%) 1(7.69%)
7 - n(%) 0(0.00%) 1(7.14%) 0(0.00%) 0(0.00%) 1(7.14%) 0(0.00%)
Total (missed) 9(0) 14(0) 14(0) 9(0) 14(0) 13(1)
  1. Note: 0 = Not assessed; 1 = Normal, not at all ill; 2 = Borderline mentally ill; 3 = Mildly ill; 4 = Moderately ill; 5 = Markedly ill; 6 = Severely ill; 7 = Among the most extremely ill patients. *The frequency of participants who scored “Mildly ill” or better was significantly increased at 24w when compared to baseline (p < 0.05). aThe frequency of participants who scored “Mildly ill” or better in the Combination or CBMNC group was significantly increased when compared with the Control group at 24w (p < 0.05). bThe frequency of participants who scored “Mildly ill” or better in the Combination group was significantly increased when compared with the CBMNC group at 24w (p < 0.05).